These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 36517125)
1. Recent progress in acute leukemia and myelodysplasia. Carraway HE; Pollyea DA; Stein EM Best Pract Res Clin Haematol; 2022 Dec; 35(4):101415. PubMed ID: 36517125 [TBL] [Abstract][Full Text] [Related]
2. Familial myelodysplastic syndrome/acute myeloid leukemia. Churpek JE Best Pract Res Clin Haematol; 2017 Dec; 30(4):287-289. PubMed ID: 29156196 [TBL] [Abstract][Full Text] [Related]
3. Integrating germline variant assessment into routine clinical practice for myelodysplastic syndrome and acute myeloid leukaemia: current strategies and challenges. Tawana K; Brown AL; Churpek JE Br J Haematol; 2022 Mar; 196(6):1293-1310. PubMed ID: 34658019 [TBL] [Abstract][Full Text] [Related]
4. Clinical utility and real-world application of molecular genetic sequencing in the management of patients with acute myeloid leukemia and myelodysplastic syndromes. Banaszak LG; Reinig E; Lasarev MR; Mattison RJ Leuk Lymphoma; 2022 Mar; 63(3):684-693. PubMed ID: 34865601 [TBL] [Abstract][Full Text] [Related]
5. Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations. West AH; Godley LA; Churpek JE Ann N Y Acad Sci; 2014 Mar; 1310(1):111-8. PubMed ID: 24467820 [TBL] [Abstract][Full Text] [Related]
6. Advances and controversies in the biology and therapy of acute leukaemia and myelodysplasia. Rowe JM Best Pract Res Clin Haematol; 2009 Dec; 22(4):475-8. PubMed ID: 19959095 [No Abstract] [Full Text] [Related]
7. Preferential occurrence of spliceosome mutations in acute myeloid leukemia with preceding myelodysplastic syndrome and/or myelodysplasia morphology. Cho YU; Jang S; Seo EJ; Park CJ; Chi HS; Kim DY; Lee JH; Lee JH; Lee KH; Koh KN; Im HJ; Seo JJ; Park SH; Park YM; Lee JK Leuk Lymphoma; 2015; 56(8):2301-8. PubMed ID: 25487075 [TBL] [Abstract][Full Text] [Related]
8. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study. Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433 [TBL] [Abstract][Full Text] [Related]
9. Applications of Circulating Tumor DNA in Myelodysplastic Syndromes and Acute Myeloid Leukemia: Promises and Challenges. Xue Y; Xia X; Liu X; Zheng Y; Gu H; Wang X Front Biosci (Landmark Ed); 2024 Feb; 29(2):86. PubMed ID: 38420833 [TBL] [Abstract][Full Text] [Related]
10. [Recent advances of studies on the therapy-related myelodysplastic syndromes/acute myeloid leukemia]. Li CJ; Zhang YZ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1757-60. PubMed ID: 25543511 [TBL] [Abstract][Full Text] [Related]
11. Unlocking the Potential of Artificial Intelligence in Acute Myeloid Leukemia and Myelodysplastic Syndromes. Alhajahjeh A; Nazha A Curr Hematol Malig Rep; 2024 Feb; 19(1):9-17. PubMed ID: 37999872 [TBL] [Abstract][Full Text] [Related]
12. Acute Leukemia Forum '98. Advances and controversies in the biology and treatment of acute myelogenous leukemia and myelodysplasia. Symposium proceedings. San Francisco, California, USA. March 6, 1998. Leukemia; 1998 Sep; 12 Suppl 1():S1-56. PubMed ID: 9841272 [No Abstract] [Full Text] [Related]
13. When to use which molecular prognostic scoring system in the management of patients with MDS? Kewan T; Bewersdorf JP; Gurnari C; Xie Z; Stahl M; Zeidan AM Best Pract Res Clin Haematol; 2023 Dec; 36(4):101517. PubMed ID: 38092484 [TBL] [Abstract][Full Text] [Related]
14. The International Consensus Classification of acute myeloid leukemia. Weinberg OK; Porwit A; Orazi A; Hasserjian RP; Foucar K; Duncavage EJ; Arber DA Virchows Arch; 2023 Jan; 482(1):27-37. PubMed ID: 36264379 [TBL] [Abstract][Full Text] [Related]
15. The new diagnostic criteria for myelodysplasia-related acute myeloid leukemia is useful for predicting clinical outcome: comparison of the 4th and 5th World Health Organization classifications. Park HS; Kim HK; Kim HS; Yang Y; Han HS; Lee KH; Son BR; Kwon J Ann Hematol; 2022 Dec; 101(12):2645-2654. PubMed ID: 36220882 [TBL] [Abstract][Full Text] [Related]
16. Cell-lineage level-targeted sequencing to identify acute myeloid leukemia with myelodysplasia-related changes. Yokoyama K; Shimizu E; Yokoyama N; Nakamura S; Kasajima R; Ogawa M; Takei T; Ito M; Kobayashi A; Yamaguchi R; Imoto S; Miyano S; Tojo A Blood Adv; 2018 Oct; 2(19):2513-2521. PubMed ID: 30282643 [TBL] [Abstract][Full Text] [Related]
17. Difference in outcomes following allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndromes. Yanada M; Mizuno S; Yamasaki S; Harada K; Konuma T; Tamaki H; Shingai N; Uchida N; Ozawa Y; Tanaka M; Onizuka M; Sawa M; Nakamae H; Shiratori S; Matsuoka KI; Eto T; Kawakita T; Maruyama Y; Ichinohe T; Kanda Y; Atsuta Y; Aoki J; Yano S Leuk Lymphoma; 2021 Dec; 62(14):3411-3419. PubMed ID: 34348554 [TBL] [Abstract][Full Text] [Related]
18. Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia. Kornblau SM; McCue D; Singh N; Chen W; Estrov Z; Coombes KR Blood; 2010 Nov; 116(20):4251-61. PubMed ID: 20679526 [TBL] [Abstract][Full Text] [Related]
19. Genetic predisposition syndromes: when should they be considered in the work-up of MDS? Babushok DV; Bessler M Best Pract Res Clin Haematol; 2015 Mar; 28(1):55-68. PubMed ID: 25659730 [TBL] [Abstract][Full Text] [Related]
20. Causality of myelodysplasia and acute myeloid leukemia and their genetic abnormalities. Pedersen-Bjergaard J; Christiansen DH; Andersen MK; Skovby F Leukemia; 2002 Nov; 16(11):2177-84. PubMed ID: 12399959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]